Jaguar8 commented on a stock · Oct 17, 2024 21:20

NEWS

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

RenovaroCube (NASDAQ: RENB), a leader in AI-driven cancer diagnostics, presented groundbreaking research at the Molecular Analysis for Precision Oncology Congress on October 16, 2024. The study explores the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) from blood plasma to detect copy number alterations (CNAs) in lung cancer patients.
Key findings include:
Effective capture of significant CNAs in lung cancer tissues
Potential for estimating tumor fractions
Reduced need for invasive tissue biopsies
This research represents a significant advancement in oncology, offering potential improvements in cancer monitoring, prognosis prediction, targeted therapy, and precise cancer subtyping. RenovaroCube continues to advance precision medicine through innovative technologies, aiming to provide more effective, patient-centered cancer care.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more